The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0

Abstract

[b][/b] Much hope is currently associated with individualization of therapy provided to rheumatoid arthritis (RA) patients. The search is underway for biochemical and clinical markers that would be useful in prediction of a good response to methotrexate (MTX) therapy. Along with clinical factors, genetic predisposition may also be helpful. Polymorphism of genes participating in MTX metabolism may affect the drug’s efficacy and the rate of adverse effects. Pharmacogenetic studies may contribute to more effective individualization of therapy for RA patients. The purpose of the study was to determine the significance of gene polymorphisms MTHFR C677T and A1298C for efficacy of MTX therapy in RA patients. Patients possessing determined polymorphisms should be particularly carefully evaluated because of a higher risk of occurrence of adverse effects.

Authors and Affiliations

Jerzy Świerkot, Ryszard Ślęzak

Keywords

Related Articles

Simple and facilitated diffusion of long chain fatty acids in the pathogenesis of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is defined as lipid accumulation in hepatocytes, in the absence of alcohol use, that exceeds 5% of liver size. The most frequent comorbidities of NAFLD include diabetes mellitus,...

Rola białka PD-1 w patogenezie chorób autoimmunizacyjnych, ze szczególnym uwzględnieniem reumatoidalnego zapalenia stawów oraz tocznia rumieniowatego układowego

Polimorfizm genu PDCD1 białka PD-1 (the programmed cell death 1, kodowane przez PDCD1) jest istotnie powiązany z częstszym występowaniem chorób autoimmunizacyjnych, takich jak reumatoidalne zapalenie stawów (RZS) oraz to...

W poszukiwaniu genu zespołu Tourette’a. Część 2. Zmienność genomu chorych

Zespół Gillesa de la Tourette’a (GTS) jest złożonym, heterogennym, uwarunkowanym genetycznie schorzeniem. W rodzinach z GTS zidentyfikowano prawie 20 rearanżacji chromosomowych (m.in.: 7q22-q31, 8q13-q22 oraz 18q22), któ...

Different mortality predictor pattern in hemodialysis and peritoneal dialysis diabetic patients in 4-year prospective observation

Introduction: The aim was to identify factors carrying an ominous prognosis in a cohort of diabetic patients (pts) on a hemodialysis (HD) and peritoneal dialysis (PD) program.Materials and methods: We analyzed survival r...

Download PDF file
  • EP ID EP66458
  • DOI -
  • Views 154
  • Downloads 0

How To Cite

Jerzy Świerkot, Ryszard Ślęzak (2011). The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2). Advances in Hygiene and Experimental Medicine, 65(0), 207-215. https://europub.co.uk/articles/-A-66458